Centre for Preclinical Imaging, University of Liverpool, Liverpool, UK.
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
J Cardiovasc Magn Reson. 2023 Feb 6;25(1):6. doi: 10.1186/s12968-023-00911-6.
Phosphorus cardiovascular magnetic resonance spectroscopy (P-CMRS) has emerged as an important tool for the preclinical assessment of myocardial energetics in vivo. However, the high rate and diminutive size of the mouse heart is a challenge, resulting in low resolution and poor signal-to-noise. Here we describe a refined high-resolution P-CMRS technique and apply it to a novel double transgenic mouse (dTg) with elevated myocardial creatine and creatine kinase (CK) activity. We hypothesised a synergistic effect to augment energetic status, evidenced by an increase in the ratio of phosphocreatine-to-adenosine-triphosphate (PCr/ATP).
Single transgenic Creatine Transporter overexpressing (CrT-OE, n = 7) and dTg mice (CrT-OE and CK, n = 6) mice were anaesthetised with isoflurane to acquire P-CMRS measurements of the left ventricle (LV) utilising a two-dimensional (2D), threefold under-sampled density-weighted chemical shift imaging (2D-CSI) sequence, which provided high-resolution data with nominal voxel size of 8.5 µl within 70 min. (H-) cine-CMR data for cardiac function assessment were obtained in the same imaging session. Under a separate examination, mice received invasive haemodynamic assessment, after which tissue was collected for biochemical analysis. Myocardial creatine levels were elevated in all mouse hearts, but only dTg exhibited significantly elevated CK activity, resulting in a 51% higher PCr/ATP ratio in heart (3.01 ± 0.96 vs. 2.04 ± 0.57-mean ± SD; dTg vs. CrT-OE), that was absent from adjacent skeletal muscle. No significant differences were observed for any parameters of LV structure and function, confirming that augmentation of CK activity does not have unforeseen consequences for the heart.
We have developed an improved P-CMRS methodology for the in vivo assessment of energetics in the murine heart which enabled high-resolution imaging within acceptable scan times. Mice over-expressing both creatine and CK in the heart exhibited a synergistic elevation in PCr/ATP that can now be tested for therapeutic potential in models of chronic heart failure.
磷心脏磁共振波谱(P-CMRS)已成为评估体内心肌能量代谢的重要工具。然而,由于小鼠心脏的高心率和小尺寸,这是一个挑战,导致分辨率低,信号噪声差。在这里,我们描述了一种改进的高分辨率 P-CMRS 技术,并将其应用于一种新型的心肌肌酸和肌酸激酶(CK)活性升高的双转基因小鼠(dTg)。我们假设协同作用会增加能量状态,表现为磷酸肌酸与三磷酸腺苷(PCr/ATP)的比值增加。
麻醉七只过表达肌酸转运蛋白的转基因(CrT-OE)和六只双转基因(CrT-OE 和 CK)小鼠,利用二维(2D)、三倍欠采样密度加权化学位移成像(2D-CSI)序列进行左心室(LV)的 P-CMRS 测量,该序列提供了具有名义体素尺寸为 8.5μl 的高分辨率数据,在 70 分钟内完成。在同一成像过程中还获得了用于心脏功能评估的(H)cine-CMR 数据。在另一项检查中,小鼠接受了侵入性血流动力学评估,然后收集组织进行生化分析。所有小鼠的心肌肌酸水平均升高,但只有 dTg 表现出 CK 活性显著升高,导致心脏中 PCr/ATP 比值升高 51%(3.01±0.96 与 2.04±0.57-均值±SD;dTg 与 CrT-OE),而相邻的骨骼肌则没有。LV 结构和功能的任何参数均无显著差异,证实 CK 活性的增强对心脏没有意外影响。
我们开发了一种改进的 P-CMRS 方法,用于活体评估小鼠心脏的能量代谢,该方法能够在可接受的扫描时间内实现高分辨率成像。在心脏中过度表达肌酸和 CK 的小鼠表现出 PCr/ATP 的协同升高,现在可以在慢性心力衰竭模型中测试其治疗潜力。